Skip to main content
OpenTrials

Clinical trial condition

Ductal Breast Carcinoma In Situ

Explore clinical trials studying Ductal Breast Carcinoma In Situ. Study availability and eligibility vary by location and protocol.

35 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Ductal Breast Carcinoma In Situ trial results

Recruiting

The PREDICT Registry:

NCT03448926

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +14 more
Locations
  • Arizona Center for Cancer Care Scottsdale, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • Sutter Health San Mateo, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
View all 30 locations
View Trial Details
Active, not recruiting

Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer

NCT01266642

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +19 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UF Cancer Center at Orlando Health Orlando, Florida, United States
  • MD Anderson in The Woodlands Conroe, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, not recruiting

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

NCT01905046

Conditions
Adenocarcinoma, Atypical Ductal Breast Hyperplasia, BRCA1 Mutation Carrier, +16 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View all 27 locations
View Trial Details

Related conditions